Phost'in Therapeutics
Phase 1/2Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases
Founded
2017
Focus
Small Molecules
About
Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases
Funding History
2Total raised: $5M
Seed$2.5MUndisclosedJan 15, 2022
Seed$2.5MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2017
LocationParis, France
StagePhase 1/2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile